Literature DB >> 1118962

An observation on the composition and recurrence of urinary calculi.

E Takasaki.   

Abstract

Seven hundred patients with 735 urinary calculi were studied for the compositions of calculi by infrared analysis and for stone recurrence. Of these 700 cases, 422 cases were possible to follow up, and 250 cases have had no further stone; 138 cases experience recurring stones, and 34 cases had multiple stones. The length of follow-up period was 1-19 years averaging 8 years, 8 months. 41.2% of patients with calcium oxalate-calcium phosphate calculi had stones recurrently, and although there was some variation of recurrence rates for patients with various proportions of oxalate to phosphate in the calculi, it was impossible to predict the tendency of recurrence by these proportions. The stone recurrence was noted in 38.6% of patients with magnesium ammonium phosphate calculi, in 38.9% with mixed magnesium ammonium phosphate-calcium oxalate calculi, in 55.6% with uric acid calculi, and in 50% with cystine calculi.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1118962     DOI: 10.1159/000279983

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  5 in total

Review 1.  Current aspects of epidemiology and nutrition in urinary stone disease.

Authors:  A Hesse; R Siener
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine.

Authors:  D Scholz; P O Schwille; D Ulbrich; W M Bausch; A Sigel
Journal:  Urol Res       Date:  1979-09

3.  Nephrolithiasis: Endocrine evaluation.

Authors:  Salam Ranabir; Manash P Baruah; K Reetu Devi
Journal:  Indian J Endocrinol Metab       Date:  2012-03

Review 4.  Epidemiology of urolithiasis in Asia.

Authors:  Yu Liu; Yuntian Chen; Banghua Liao; Deyi Luo; Kunjie Wang; Hong Li; Guohua Zeng
Journal:  Asian J Urol       Date:  2018-09-06

5.  Vitamin C inhibits crystallization of struvite from artificial urine in the presence of Pseudomonas aeruginosa.

Authors:  Muhammed A P Manzoor; Surya Ram Duwal; M Mujeeburahiman; Punchappady-Devasya Rekha
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.